Ixaka is an England-based biotechnology company that develops and commercializes cell and gene therapies for the treatment of cardiovascular and neurological diseases.
Business Model:
Revenue: $5.2M
Employees: 51-200
Address: 45 Pont Street
City: London
State: england
Zip: SW1X 0BD
Country: GB
Ixaka is an England-based biotechnology company that develops and commercializes cell and gene therapies for the treatment of cardiovascular and neurological diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2016 | Series A | 1 | $14.2M |
ZenPharma Limited ZenPharma Limited ZenPharma Limited ZenPharma Limited |
8/2019 | Grant | 1 | $323.9k |
Innovate UK Innovate UK Innovate UK Innovate UK |
1/2021 | Venture Round | 1 | $54M |
ZenPharma Limited ZenPharma Limited |
1/2018 | Grant | 1 | $2M |
Innovate UK Innovate UK Innovate UK Innovate UK |
6/2015 | Seed Round | 1 | $2.1M |
ZenPharma Limited ZenPharma Limited ZenPharma Limited ZenPharma Limited |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|